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[ 3H)G1utamic acid incorporation in vivo into hairless mouse epidermal pyrrolidone carbox-
ylic acid (PCA) was followed with time after a single subcutaneous injection. PCA specific 
activity increased slowly, reaching a peak at 3 to 4 days after injection of the labeled amino 
acid, after wlllch it slowly declined. Incorporation of [3H)glutamic acid into epidermal PCA 
was markedly inhibited by a single topical application of cycloheximide. Topical application 
of cycloheximide 2 hr prior to PH)glutamate injection caused a significantly greater reduc-
tion in PCA specific activity (determined 3 days after injection) than cycloheximide treat-
ment 3 hr after administration of the labeled amino acid. Ninety-seven percent of the PCA 
content of hairless mouse epidermis was shown to reside in the stratum corneum. These 
observations indicate the involvement of protein synthesis in the formation of PCA from 
glutamic acid rather than a direct conversion of the amino acid. The lllgh level of PCA in 
mammalian epidermis appears to be caused by its accumulation in the stratum corneum 
accompanied by a relatively slow rate of PCA turnover in comparison to other tissues. 
Pyrrolidone carboxylic acid (PCA) has been 
shown to be a major soluble nitrogenous constitu-
ent of mammalian epidermis from a variety of 
species including man [1,2]. Wolfersberger, Ta-
bachnick , Finkelstein, and Levin provided data 
indicating that the high levels of PCA in epider-
mis in comparison to other tissues resulted from 
local enzymatic biosynthesis rather than accumu-
lation from the blood stream or from metabolism 
by skin surface microbes [1,3]. Although Wolfers-
berger and Tabachnick [3] described four en,zyme 
activities in guinea-pig epidermal homogenates 
capable of PCA formation from different sub-
strates, the major route of its biosynthesis and the 
physiologic reasons for its high concentration in 
epidermis remain unknown. In order to provide 
more information on the major physiologic route 
for PCA accumulation in the epidermis, we have 
employed in vivo labeling studies using hairless 
mice. The results suggest the involvement of pro-
tein synthesis in the formation of PCA from glu-
tamic acid. 
MATERIALS AND METHODS 
Chemicals . L-l3-3H) glutamic acid (sp act 15-25 Ci/ 
mmole) and L-[U-14C]glutamic acid (sp act 225 mCi/ 
mmole) were obtained from New England Nuclear 
Corp. Ag 50 W x 8 (100-200 mesh) and Ag-1 x 10 (200-
400 mesh) ion exchange resins were purchased from Bio 
Rad Laboratories. Cellulose-coated plastic thin-layer 
plates were obtained from Brinkmann Instruments. 
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Cycloheximide and crystalline trypsin were from 
Sigma. 
Animal treatments and preparation of epidermal ho-
mogenates. Two- to three-month-old hairless mice of 
either sex (HRS/J strain) were obtained from Jackson 
Laboratories. For in vivo labeling studies animals were 
injected subcutaneously with 10 ~LCi/animal of [3H]- or 
L 14C]gl utamic acid in saline. Cycloheximide was applied 
topically by painting 0.2 m.1 of a 0.1% solution in ace-
tone onto the dorsal skin of each mouse with a small 
brush. Controls were painted with acetone alone. Mice 
were sacrificed by decapitation and excised skins were 
placed in 0.15 M NaCl at 4°C for periods of up to 30 min. 
Full-thickness skins were immersed in 0.15 M NaCI at 
58-60°C for 1 min after which they were removed, blot-
ted, and the epidermis was scraped from the dennis 
with a scalpel. In one experiment, in which exposure to 
NH3 vapor was used for epidermal separ ation, the ex-
cised skins were not immersed in saline solution. The 
surface of each skin sample was wiped with a saline-
moistened wipe, and the full-thickness skins were ex-
posed to NH3 vapor in a desiccator for 3 min after which 
they were removed and the epidermis was obtained by 
scraping from the dermis with a scalpel. 
Epidermal samples were homogenized in water using 
a ground-glass pestle and matching glass vessel held in 
cracked ice. Sufficient HC104 was added to give a con-
centration of 0.5 N , and the homogenates were chilled 
on ice for 30 min followed by centrifugation to obtain 
the acid-soluble fraction. The acid-insoluble precipi-
tates were washed once with 0.3 N HClO. and the 
resulting supernatant fractions after centrifugation 
were added to the original ones. Acid-soluble fractions 
were adjusted to pH 4.5 with KOH and the precipitate 
which formed after chilling on ice for 30 min was re-
moved by centrifugation. 
Isolation and determination of epidermal PCA. Acid-
soluble fractions (pH 4.5) from individual hairless 
mouse dorsal epidermal samples (0.15-0.25 gm) were 
drained onto 0.6 x 7.5 em columns of Ag 50 H+ cation 
exchange resin. Initial effluents were collected along 
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with an additional wash with 6 ml of deionized water. 
Ag 50 H+ water washes were adjusted to pH 6-7 and 
were drained onto 0.6 x 7.5 em columns of Ag-1-for-
mate. Ag-1-formate was prepared from Ag-1-chloride by 
washing with 3M sodium formate [4]. The Ag-1-formate 
columns were washed with 10 ml of deionized water and 
PCA was eluted with 10 ml of 0.5 N HCl. Aliquots (0.5 
ml) of the eluted PCA samples were mixed with 0.05 ml 
of concentrated HCI and were hydrolyzed for 90 min at 
1oo•c. The acid-hydrolyzed samples were assayed for 
ninhydrin color by the method of Rosen [5]. In labeling 
studies, 1-ml aliquots of the PCA eluates were mixed 
with 10 ml of PCS scintillation cocktail (Amersham/ 
Searle), and radioactivity was determined by counting 
in a Packard liquid scintillation spectrometer. In some 
cases Ag 50 H+ water washes were drained onto a 0.7 x 
20 em column of Ag-1-formate, and, after the column 
was washed with 40 ml of deionized water, PCA was 
eluted using a 0-1.0 N linear gradient of HCl. Column 
fractions were hydrolyzed, assayed for ninhydrin color, 
and counted as above. In experiments where pooled 
dorsal epidermal samples from 4 to 5 animals were 
analyzed, acid-soluble fractions were drained through a 
larger Ag 50 H+ column (1 x 20 em) than was used for 
single samples. 
T hin-layer chromatography of isolated PCA . Six 
hairless mice were injected with [3H]glutamic acid and 
after 4 days the animals were sacrificed. PCA was 
isolated from each dorsal sample as described above. 
Prior to elution of the small Ag-1-formate columns, 
each was washed with 150 ml of deionized water to 
remove all traces of salt. The isolated samples were 
pooled and lyophilized to dryness. The residue was 
taken up in a small volume of 1 N HCI, a:1d an aliquot 
was spotted on a cellulose thin-layer plate alongside a 
sample of authentic PCA. The remainder of the sample 
was hydrolyzed at 1oo•c for 90 min, and an aliquot of 
the hydrolyzed material was spotted on a second thin-
layer plate alongside authentic glutamic acid. Both 
plates were developed with butanol:acetic acid:water 
(80:50:30). After development and drying, the paths of 
migration of the unhydrolyzed epidermal sample and 
the authentic PCA sample were each cut into strips 
from the origin up to the solvent front. Each strip was 
eluted overnight in 1 N HCl and aliquots of each frac-
tion were hydrolyzed and tested for ninhydrin color. 
Aliquots of each fraction were also counted for radioac-
tivity. The thin-layer plate containing the hydrolyzed 
epidermal sample was sprayed with ninhydrin and was 
heated to develop the color. After the position of ninhy-
drin-positive material was noted with reference to the 
glutamic acid standard spot, the plate was divided into 
fractions which were eluted and counted for radioactiv-
ity. 
Determination of the effects of topically applied cyclo-
heximide on epidermal protein synthesis. Two groups of 
hairless mice (9 animals per group) were treated topi-
cally with either acetone or 0.1% cycloheximide in ace-
tone as described above. At 2, 6, and 24 hr after topical 
treatment, 3 animals from each group were injected 
subcutaneously with [14C)glutamic acid. One hour after 
injection the animals were sacrificed and epidermal 
samples were obtained from the treated dorsal skin as 
well as from the untreated belly skin by the heating 
method. Epidermal samples were weighed and homoge-
nized (see above), and the resulting acid-insoluble pre-
cipitates were washed twice with 0.3 N HCI04 and once 
with water to remove all acid-soluble materiaL The 
precipitates were then suspended in water and 0.5-ml 
aliquots of each suspension were mixed with 1 ml of 
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Protosol (New England Nuclear) and were left at room 
temperature for 5 hr. Ten milliliters of PCS scintilla-
tion cocktail (Amersham/Searle) was then arlded to 
each sample and they were thoroughly mixed and left 
for 24 hr prior to counting in a Packard liquid scintilia-
tion spectrometer. 
Determination of the PCA content of whole epidermis 
and stratum corneum. Excised dorsal skins from 2 hair-
less mice were cut in half. Epidermal samples were 
obtained from each piece of skin by the heating tech-
nique and 2 halves (1 from each animal) were pooled for 
determination of whole epidermal PCA content while 
the other 2 halves were used for isolation of stratum 
corneum. The wet weight of the 2 epidermal samples 
was as follows: 0.206 gm (sample for whole epidermal 
analysis!, and 0.205 gm (sample for stratum corneum 
preparation). The epidermal samples used for isolation 
of stratum corneum were floated, stratum corneum side 
up, for 30 min at 25•c on 0.1% trypsin solution in 0.15 M 
NaCl buffered to pH 7.4 with 0.05 M Tris-HCL They 
were then rinsed in saline and were turned stratum 
corneum side down on a saline-moistened glass plate. 
The digested viable epidermis was gently removed by 
rubbing with a moist cotton swab. The whole epidermal 
and stratum corneum samples were homogenized and 
processed for isolation of PCA. The DNA content of the 
acid-insoluble material from each sample was deter-
mined as described by DeLapp and Karasek [6) to esti-
mate the degree of contamination of the stratum cor-
neum preparation by viable epidermal tissue. 
RESULTS 
Isolation of PCA from Hairless Mouse Epidermis 
Figure 1A shows a chromatogram of a mixture 
ofPCA andN-acetyl glutamic acid run on an Ag-1-
formate column eluted with a 0-l N HCI linear 
gradient. This system is capable of separating 
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FIG. L Column chromatography of epidermal PCA 
isolated 4 days after [3H]glutamate injection. A: Chro-
matography of a mixture of authentic PCA and N-
acetyl glutamic acid on Ag-1-formate. B: Chromatogra-
phy of epidermal PCA radiolabeled in vivo. Isolation of 
PCA and column chromatography are described under 
Materials and Methods . ~~ = Absorbance at 570 
nm; • --• = 3H-dpm. 
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FIG. 2. Thin-layer chromatography of in vivo radiola-
beled PCA, flrst isolated from epidermis by column 
chromatography. PCA isolation and chromatography 
are described under Materials and Methods . A : Chro-
matography of authentic PCA (upper) and isolated epi-
dermal material (lower) on the same plate. Fractions 
were eluted, acid hydrolyzed, and assayed for ninhy-
drin color and radioactivity. B: Chromatography of the 
epidermal material after acid hydrolysis. The plate was 
sprayed to reveal ninhydrin-positive areas and frac-
tions were eluted and counted for radioactivity. 0 0 
= Absorbance at 570 nm; e------e = 3H dpm. 
these two similar compounds neither of which are 
retained on an Ag 50 H+ column at pH 4.5 due to 
the absence of an unsubstituted amino group. N-
acetyl glutamic acid is eluted somewhat later than 
PCA due to its free gamma carboxyl group in 
addition to the alpha carboxyl group causing it to 
bind more firmly to the anion exchange resin. In 
Figure 1B a chromatogram of an epidermal sam-
ple run on the same column is shown. This sample 
was obtained from a pool of 5 dorsal epidermal 
tissues taken from animals which had been in-
jected with I3H]glutamic acid 4 days prior to sacri-
fice . The acid-soluble material was first passed 
through a 1 x 20 em column of Ag 50 H+ prior to 
chromatography 0:1 Ag-1-formate. It is evident 
that the position of ninhydrin-positive material 
corresponds to the position of the authentic PCA 
chromatographed in Figure 1A . Only 1 peak of 
ninhydrin-positive material (determined after 
acid hydrolysis of all fractions- see Materials and 
Metlwds) appeared and only 1 peak of radioactiv-
ity corresponding to the color peak was detected. 
Since only 1 peak of ninhydrin color and radioac-
tivity was found using gradient elution of Ag-1-
formate, it appeared that a satisfactory purifica-
tion of PCA could be obtained by a 1-step elution 
from washed Ag-1-formate using 0.5 N HCl, thus 
PCA BIOSYNTHESIS IN MAMMALIAN EPIDERMIS 295 
eliminating the necessity of fraction collection for 
each sample analyzed. Figure 2 shows a thin-layer 
chromatogram of a pooled PCA sample isolated by 
the combined use of small Ag 50 H+ and Ag-1-
formate colums for each skin sample (see Materi-
als and Methods ). In Figure 2A it can be seen that 
material eluted from the plate and rendered nin-
hydrin-positive by acid hydrolysis corresponds in 
position to the authentic PCA standard which was 
chromatographed on the same plate. Only 1 peak 
of ninhydrin color was obtained, and also only 1 
radioactive peak was detected which co-migrated 
with the color peak. After acid hydrolysis of the 
column-isolated PCA, thin-layer chromatography 
revealed only 1 spot corresponding in position to 
the glutamic acid standard chromatographed on 
the same plate. Figure 2B shows that the radioac-
tivity which migrated with PCA prior to acid hy-
drolysis appeared in the spot corresponding to glu-
tamic acid after hydrolysis. The small amount of 
radioactivity in fraction 10 is located at the posi-
tion of PCA migration and probably represents a 
small amount of material that was not hydrolyzed. 
Effect of Epidermal S eparation Method on PCA 
Content 
Table I shows the PCA content on a wet-weight 
basis of epidermal samples obtained either by im-
mersion in 0.15 M NaCl at 60°C or by exposure to 
NH3 vapors. There was no significant difference in 
epidermal PCA content with these two separation 
techniques, showing that immersion of full-thick-
ness skins in physiologic saline solutions for the 
time intervals used in these experiments (see Ma-
terials and Metlwds) does not extract significant 
amounts of PCA from the epidermis. The saline 
immersion technique was used throughout this 
study for obtaining epidermal samples. 
Time-Course of [=IH)Glutamic A cid Incorporation 
into Epidermal PCA 
In Figure 3 the specific activity ofPCA is plotted 
versus time of isolation after a single injecton of 
[ 3H]glutamic acid. Incorporation of [3H]glutamic 
acid into epidermal PCA in vivo was very slow, 
resulting in a gradually increasing specific activ-
ity which peaked at 3 to 4 days after injection and 
then slowly declined. 
TABLE I. Effect of epidermal separation method 
on PCA content 
Dorsal epidermal samples were obtained by the sepa-
ration methods indicated in the Table as described un-
der Materials and Methods, and were analyzed for PCA 
content on a wet-weight basis. Data are the mean :t SD 
of determinations on 5 mice. 
Epidermal separation 
method 
NH3 vapors 
Immersion in 60°C saline 
solution 
PCA content 
(1-'mole/gm epidermis) 
25.8 :!: 4.6 
28.1 :!: 6.1 
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DAY'S AfTR rttl GUITAMAR INJKTION 
FIG. 3. Time-course of [3H]glutam ic acid incorpora-
tion into epidermal PCA. I1Uection of [3H]glutamic acid 
and isolation of PCA are described under Mate rials and 
Methods. Each data point is the mean from 3 separate 
experiments :!: SD. Points represent 7 determinations 
except for days 5 and 6, each of which is the mean of 4 
determinations. 
Effects of Topical Cycloheximide on Radiolabeled 
Glutamic A cid Incorporation into Epidermal 
Protein and PCA 
Table II shows the incorporation of 
[ 14C)glutamic acid into epidermal acid-insoluble 
material at different time intervals after a single 
application of either acetone or 0.1% cyclohexi-
mide in acetone to the dorsal skin. Dorsal epider-
mal protein synthesis was strongly inhibited at all 
time intervals examined up to 24 hr after the 
topical dose. Marked inhibition of untreated belly-
skin epidermal protein synthesis over the same 
time interval shows that substantial amounts of 
cycloheximide were absorbed systemically by this 
route. 
In Figure 4 dorsal epidermal PCA specific activi-
ties were determined daily for 4 days after injec-
tion of [3H]glutamic acid into mice treated topi-
cally 2 hr prior to injection with either acetone 
(controls) or 0.1% cycloheximide in acetone. The 
single application of cycloheximide resulted in a 
marked inhibition of [3H]glutamate incorporation 
into epidermal PCA. Acetone treatment alone did 
not appear to affect labeling of PCA. On day 3 
after treatment, the epidermal PCA content of the 
cycloheximide-treated mice was noted to be re-
duced on a wet-weight basis (data not shown); 
however, this appeared to be due largely to an 
increase in dorsal epidermal wet weight in the 
cycloheximide-treated group. The experiment was 
repeated except that mice were sacrificed only on 
day 3 after topical cycloheximide treatment and 
( 3H]glutamate injection. Table ill shows again the 
marked reduction in PCA specific activity 3 days 
after cycloheximide treatment in comparison to 
the acetone-treated controls. The dorsal epidermal 
PCA content on a wet-weight basis was signifi-
cantly reduced, but this was the result of an in-
crease in epidermal wet weight in the cyclohexi-
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mide-treated mice. There was no significant differ-
ence in the total PCA isolated per dorsal epider-
mal sample from controls or cycloheximide-treated 
animals, and the PCA content per mg epidermal 
DNA was significantly higher in the cyclohexi-
mide-treated group due to a reduction in epider-
mal DNA content caused by the inhibitor. At time 
of sacrifice the skin of the cycloheximide-treated 
mice was noted to be somewhat red and scaly, 
indicating irritation at the concentration used. 
Table IV shows two experiments in which topi-
cal cycloheximide was applied 3 hr after injection 
of [3H]glutamic acid rather than 2 hr prior to 
injection as in Figure 4 and Table Ill. The PCA 
specific activity from epidermal samples obtained 
3 days after treatment was again substantially 
TABLE II. Effect of topically applied cycloheximide on 
1 1"'C]glutamic acid incorporation into treated (dorsa/) 
and untreated (belly) epidermal acid-insoluble material 
Cycloheximide (0.1 %) in acetone or acetone alone 
was applied to the dorsal skin as described in Materials 
and Methods . At the indicated time intervals after 
treatment, groups of animals were injected with 
l"C]glutamate and were sacrificed 1 hr after injection 
for determination of isotope incorporation into acid-
insoluble material. Each number is the mean ::t SD 
from 3 animals . 
[~<C]Glutamic acid incorporated 
Hours after (dpmlmg epidermis) 
topical cy-
clohexim- Dorsal epidermis Belly epidermis 
ide applica-
tion Controls Cyclohex- Controls Cyclohex-imide imide 
2 64 :!: 8 8±3 29 :!: ] 6 :!: 1 
6 90 ± 17 21 :!: 12 29 ± ] 8 :!: 2 
24 79 :!: 2 16 :!: 5 32 ± 3 12 :!: 1 
2 
DAYS AFTER [3H] GLUTAMATE INJECTION 
FIG. 4. Effect of topical cycloheximide on 
[ 3H]glutamate incorporation into epidermal PCA. Cy-
cloheximide treatment and PCA isolation are described 
under Materials and Methods. Each point is the mean :!: 
SD from determinations on 3 aminals. Q--tlii) = Con-
trols; • --• = cycloheximide-treated. 
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TABLE III. Effect of cycloheximide on epidermal PCA content and specific actiuity determined 3 days after topical 
application and {3H]glutamic acid injection 
Hairless mice were treated topically with either acetone or 0.1% cycloheximide in acetone as described under 
~aterials and Methods. Two hours after topical treatment all mice were i.Iijected with [3H]glutamic acid and were 
.;acrificed 3 days after injection. All values in the Table are the mean ± SD from 5 animals. P values were 
determined using Student's t-test for paired data. 
Dorsal ~idermal Epidermal PCA content PCA specific epidermal Treatment D A content wet weight 
(gm) (mg/gm) (!J.mole/samplel (~-tmole/gm) (p.mole/mg DNA) 
activity 
(dprn!~-tmo!e) 
Controls 0.177 ± 0.01 3.55 ± 0.16 4.64 ± 0.68 26.1 ± 3.2 7.36 ± 2.1 806 ± 80 
p < 0.005 p < 0.001 p > 0.2 p < 0.025 p < 0.05 p < 0.001 
Cycloheximide 0.250 ± 0.03 2.25 ± 0.18 4.87 ± 0.67 19.5 ± 1.8 8.68 ± 0.6 22 ± 6 
treated 
T ABLE IV. Effect of cycloheximide applied subsequent to 
(3H]glutamate injection on PCA specific actiuity 
determined 3 days after treatment 
Hairless mice were i.Iijected with [3H]glutamic acid 
followed 3 hr later by topical application of acetone or 
0.1% cycloheximide in acetone as described under Mate-
rials and Methods. Three days after topical treatment 
the animals were sacrificed for determination of epider-
1 mal PCA specific activities. Values are the mean ± SD 
from 5 animals. P values were calculated using Stu-
dent's t-test for paired data. 
Experi-
ment Treatment PCA specific activity 
number 
1 Controls 1403 ± 378 p < 0.005 Cycloheximide 356 ± 83 
2 Controls 1214 ± 174 p < 0.005 Cycloheximide 448 :!: 147 
reduced in comparison to the controls, but the 
degree of inhibition caused by cycloheximide ap-
plication subsequent to [='H]glutamate injection 
(63-75%) was found to be significantly different (p 
< 0.001) from that due to application prior to injec-
tion (94-97%-Fig. 4 and Tab. IIIl. 
PCA Content of Whole Epidermis and Stratum 
Corneum 
PCA has been shown to be present in stratum 
corneum samples from normal and psoriatic skin 
[2,7]. It was of interest to determine how much of 
the hairless mouse epidermal PCA was contained 
within the stratum corneum in comparison to the 
viable epidermis. Table V compares the PCA and 
DNA content of whole epidermis with a stratum 
corneum preparation obtained by trypsinization of 
an equivalent amount of epidermis (see Materials 
and Methods). Although the DNA content of the 
stratum corneum preparation was only 4% of that 
of the whole epidermal sample, indicating that it 
was substantially free of viable epidermal cells, its 
PCA content was 97% of the whole epidermal 
level. On a wet-weight basis isolated stratum cor-
neum was found to contain more than twice the 
PCA content of whole epidermis (data not shown). 
TABLE V. PCA content of whole epidermis and trypsin-
isolated stratum corneum 
Two epidermal samples (equivalent on a wet-weight 
basis) were obtained and one was treated for isolation of 
stratum corneum by removal of viable epidermal cells 
with trypsin as described under Materials and Methods . 
The PCA content of the whole epidermal sample and 
the stratum corneum preparation was then determined. 
The DNA content of each sample was also determined 
to estimate the purity of the stratum corneum prepara-
tion. 
Tissue 
Whole epidermis 
Stratum corneum 
PCA content 
(~-tmolel 
4.07 
3.94 
DISCUSSION 
DNA content (mg) 
1.08 
.04 
In this study PCA was isolated from epidermis 
via the combined use of Ag 50 H+ and Ag-1-for-
mate ion exchange columns. Although Ag 50 H+ 
ion exchange columns alone have been used satis-
factorily for quantitating epidermal PCA [1], we 
found that material isolated using only Ag 50 H+ 
columns from animals which had been injected 
with [3H]glutamic acid was heavily contaminated 
by non-PCA radioactive impurities. These impuri-
ties are effectively removed by subsequent use of 
Ag-1-formate columns since they bind strongly to 
the anion exchanger and are not eluted along with 
PCA by 0.5 N HCI. 
The observed time-course for labeling of hairless 
mouse epidermal PCA following injection of 
[ 3H]glutamic acid poses some limitations on the 
probable major route for PCA biosynthesis in this 
tissue. Guinea-pig homogenates have been shown 
to catalyze formation of PCA directly from glu-
tamic acid or glutamine [3]. This route seems to be 
most unlikely as a candidate for epidermal PCA 
accumulation, since rapid labeling of PCA should 
occur via such a direct pathway. Likewise, the 
classic gamma glutamyl cycle which occurs in a 
variety of tissues [8], if responsible for the major-
ity of epidermal PCA formation, would also ex-
hibit rapid labeling kinetics as observed for uri-
nary PCA following systemic administration of 
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labeled glutamic acid to humans [9]. Such path-
ways may exist in the epidermis but probably 
account for only a small percentage of epidermal 
PCA synthesis. The most likely explanation for 
the observed labeling pattern is that 
[ 3H)glutamate is fl.rst incorporated into a reservoir 
from which PCA formation subsequently takes 
place. The peak in PCA specific activity at 3 to 4 
days after [3H)glutamate injection is not far re-
moved from the reported hairless mouse stratum 
corneum turnover time of 4 to 5 days [10]. This 
observation, coupled with the high percentage of 
PCA within the stratum corneum demonstrated in 
this study, suggests that the drop in PCA specific 
activity, which begins 3 days after injection of the 
labeled amino acid, results from desquamation of 
horny cells containing labeled PCA and replace-
ment by continued synthesis of PCA from nonra-
dioactive precursors. 
Our working hypothesis is that [3H]glutamic 
acid is first incorporated into a pool of slowly turn-
ing over material which is converted over a period 
of days into epidermal PCA. Since topical cyclo-
heximide application 3 hr after injection of 
[ 3H]glutamate resulted in 70% of the inhibition 
observed with treatment 2 hr prior to injection 
(see Tab. IV in comparison to Tab. ill and Fig. 4), 
it would appear that the predominate effect of 
cycloheximide observed in this study resulted from 
inhibition of synthetic steps subsequent to deposi-
tion of [3H]glutamate into the above-mentioned 
hypot.heiical pool. Cycloheximide-induced reduc-
tion of enzyme activities involved in the final steps 
ofPCA biosynthesis could account for the majority 
of PCA specific activity reduction. The signill-
cantly greater reduction in [3H]glutamate conver-
sion to PCA observed when cycloheximide was 
present during maximal availability of the radio-
active amino acid to mouse tissues (the fl.rst few 
hours after injection) suggests that part of the 
reduction observed was due directly to protein syn-
thesis inhibition. Initial incorporation of 
[ 3H]glutamic acid into a protein pool prior to con-
version into epidermal PCA is an attractive hy-
pothesis which would explain the labeling kinetics 
observed and would also supply a possible source 
of known substrates for PCA biosynthesis: gamma 
glutamyl and pyrrolidonyl peptides [3]. Although 
the level of such peptides in guinea-pig epidermis 
has been reported to be very low [3), this fact does 
not rule out their involvement in formation of the 
high epidermal PCA levels which have been ob-
served [1). Continuous PCA synthesis from 1 or 
more protein pools which are converted into pep-
tide intermediates could involve peptide pools of 
any size. It appears to us that the high concentra-
tion ofPCA in mammalian epidermis results from 
its slow turnover rate in this tissue (presumably 
due to accumulation in the stratum corneum and 
loss via desquamation) in comparison to other or-
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gans where PCA turnover is rapid [8,9]. The obser-
vation that topically applied cycloheximide was 
absorbed in substantial amounts systemically 
leaves open the possibility that its effects on 
[ 3H]glutamate incorporation into epidermal PCA 
resulted from action on other organ systems. Al-
though the fmal formation of PCA probably takes 
place directly in the epidermis [1,3], transfer of a 
precursor for its biosynthesis from the circulation 
cannot be ruled out. In view of the marked reduc-
tion in PCA specifl.c activity observed 3 days after 
[ 3H]glutamic acid injection of cycloheximide-
treated mice, it is surprising that the epidermal 
concentration was not affected more dramatically 
(Tab. III). Cycloheximide is a known inhibitor of 
hairless mouse epidermal DNA synthesis lll] as 
well as protein synthesis. It may be that inhibition 
of epidermal DNA synthesis in these animals (cy-
cloheximide-treated mice had lower levels of epi-
dermal DNA-Tab. ill) resulted in a decreased 
rate of epidermal turnover and hence a reduction 
in the loss of PCA due to reduced stratum corneum 
turnover. Hopefully, future experiments will elu-
cidate the molecular details of epidermal PCA bio-
synthesis. We anticipate that such knowledge will 
shed new light on the epidermal keratinization 
process. 
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